Mysoline (primidone) is an anticonvulsant used to treat epilepsy. AstraZeneca divested the marketing authorisations for manufacture and sale of Mysoline to AcorusTherapeutics Ltd in July 2004. Forfurther details, visit www.acorus-therapeutics.com.
Did you know?
AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.
Links to country-specific websites can be found using the AstraZeneca websites list.
If you still have a question regarding our drug portfolio you can Contact us.
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
